Lv12
70 积分 2025-07-26 加入
MiR-337-3p lowers serum LDL-C level through targeting PCSK9 in hyperlipidemic mice
21分钟前
已完结
The atherosclerotic plaque microenvironment: cellular plasticity, extracellular matrix remodeling, and plaque stability
57分钟前
求助中
Therapeutic Effects of PCSK9 Inhibitors on Lp(a)-Associated Atherosclerosis: Evidence and Perspectives
1个月前
已完结
MiR-146a encapsulated liposomes reduce vascular inflammatory responses through decrease of ICAM-1 expression, macrophage activation, and foam cell formation
1个月前
已完结
Relationship Between the Severity of Coronary Artery Disease and Renal Function
5个月前
已完结
Association Between Physiological Significance and Vulnerable Plaque Characteristics in Patients With Myocardial Infarction
5个月前
已完结
Lipoprotein(a), Cholesterol, Triglyceride Levels, and Vulnerable Coronary Plaques
6个月前
已完结
Early Initiation of PCSK9 Inhibitor Therapy Versus Placebo in Patients With Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
10个月前
已完结
Lipoprotein(a) lowering and cardiovascular risk reduction by PCSK9 inhibitors
10个月前
已完结
Salvianic acid A ameliorates atherosclerosis through metabolic-dependent anti-EndMT pathway and repression of TGF-β/ALK5 signaling
1年前
已完结
皖公网安备34019202002308
